These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33122505)

  • 21. The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d.
    Sacks HS
    Ann Intern Med; 2021 Jul; 174(7):JC75. PubMed ID: 34224270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2.
    Vernon JJ; Black EVI; Dennis T; Devine DA; Fletcher L; Wood DJ; Nattress BR
    J Dent Res; 2021 Dec; 100(13):1461-1467. PubMed ID: 34338580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of aerosol production and aerosol dispersion during otologic surgery.
    Gomez Serrano M; Santiago-Saez A; Moreno Rodriguez R; Lopez Salcedo A; Poch Perez-Botija A; Aragones Sanzen-Baker W; García Martín AF; García García JA; Iglesias Moreno MC
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3363-3369. PubMed ID: 34480224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRIORITY risk model predicted critical outcomes in patients hospitalized with COVID-19.
    Boreskie P; Lang E
    Ann Intern Med; 2021 Dec; 174(12):JC143. PubMed ID: 34871045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of Particle Size and Viability of SARS-CoV-2 Aerosols from a Range of Nebuliser Types Using a Novel Sampling Technique.
    Paton S; Clark S; Spencer A; Garratt I; Dinesh I; Thompson KA; Bennett A; Pottage T
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
    Irfan N; Chagla Z
    Ann Intern Med; 2021 May; 174(5):JC50. PubMed ID: 33939483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In suspected COVID-19, RT-PCR with nasal plus throat swabs has 97% sensitivity vs. nasopharyngeal swabs.
    Maki DG
    Ann Intern Med; 2021 Sep; 174(9):JC107. PubMed ID: 34487439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental evaluation of aerosol mitigation strategies in large open-plan dental clinics.
    Zhu M; Medina M; Nalliah R; Kadhium V; Bell E; Han T; Boehman A; Capecelatro J; Wooldridge M
    J Am Dent Assoc; 2022 Mar; 153(3):208-220. PubMed ID: 34952683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Use of Vitamin B2 as a Fluorescent Tracer in Aerosol and Droplet Contamination Models in Otolaryngology.
    Sim ES; Dharmarajan H; Boorgu DSSK; Goyal L; Weinstock M; Whelan R; Freiser ME; Corcoran TE; Jabbour N; Wang E; Chi DH
    Ann Otol Rhinol Laryngol; 2021 Mar; 130(3):280-285. PubMed ID: 32795090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosol-generating procedures in the COVID era.
    Hamilton GS
    Respirology; 2021 May; 26(5):416-418. PubMed ID: 33660369
    [No Abstract]   [Full Text] [Related]  

  • 31. Viral aerosol transmission of SARS-CoV-2 from simulated human emission in a concert hall.
    Schade W; Reimer V; Seipenbusch M; Willer U; Hübner EG
    Int J Infect Dis; 2021 Jun; 107():12-14. PubMed ID: 33857608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation.
    Lee BU
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Size distribution of exhaled aerosol particles containing SARS-CoV-2 RNA.
    Alsved M; Nygren D; Thuresson S; Fraenkel CJ; Medstrand P; Löndahl J
    Infect Dis (Lond); 2023 Feb; 55(2):158-163. PubMed ID: 36331347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.
    Chaudhuri D; Rochwerg B
    Ann Intern Med; 2022 Feb; 175(2):JC18. PubMed ID: 35099996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic ear surgery during COVID-19 pandemic.
    Tengku Kamalden TMI; Misron K
    Med J Malaysia; 2021 Aug; 76(Suppl 4):42-44. PubMed ID: 34558558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling aerosol transmission of SARS-CoV-2 from human-exhaled particles in a hospital ward.
    Saw LH; Leo BF; Nor NSM; Yip CW; Ibrahim N; Hamid HHA; Latif MT; Lin CY; Nadzir MSM
    Environ Sci Pollut Res Int; 2021 Oct; 28(38):53478-53492. PubMed ID: 34036501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosol transmission of SARS-CoV-2 by children and adults during the COVID-19 pandemic.
    Moschovis PP; Yonker LM; Shah J; Singh D; Demokritou P; Kinane TB
    Pediatr Pulmonol; 2021 Jun; 56(6):1389-1394. PubMed ID: 33624927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In adults, NSAID use vs. nonuse in the past 4 mo was not linked to increased risk for COVID-19-related mortality.
    Varner CE
    Ann Intern Med; 2021 May; 174(5):JC58. PubMed ID: 33939487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interdisciplinary Perspectives on the Role of Aerosol Transmission in SARS-CoV-2 Infections].
    Held A; Dellweg D; Köhler D; Pfaender S; Scheuch G; Schumacher S; Steinmann E; Weingartner E; Weinzierl B; Asbach C
    Gesundheitswesen; 2022 Jul; 84(7):566-574. PubMed ID: 35835094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol generating procedural risks and concomitant mitigation strategies in orthodontics amid COVID-19 pandemic - An updated evidence-based review.
    Singh H; Maurya RK; Sharma P; Kapoor P; Mittal T
    Int Orthod; 2021 Sep; 19(3):329-345. PubMed ID: 34088619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.